Literature DB >> 26962388

The Effect of Melasma on the Quality of Life in a Sample of Women Living in Singapore.

Ochi Harumi1, Chee Leok Goh1.   

Abstract

INTRODUCTION: Melasma is a common disorder of acquired hyperpigmentation characterized by irregular brown macules and patches that occur primarily on sun-exposed areas.
METHODS: This was a prospective cross-sectional study that recruited 49 women clinically diagnosed with melasma from a tertiary dermatology referral center in Singapore. Trained investigators assessed the melasma severity objectively using the chromameter and mexameter and subjectively using the Melasma Area and Severity Index. The effect of melasma on the quality of life on the patients was assessed using the melasma quality of life scale and dermatology life quality index questionnaires.
RESULTS: The mean ± SD Melasma Area and Severity Index score was 12.1±6.5 (median 10.8). The mean ± SD melasma quality of life scale score was 25.6±15.3 (median 24.0). Melasma quality of life scale scores are significantly correlated (Spearman's coefficient = 0.597, p-value <0.001) with the dermatology life quality index scores. There was no correlation between Melasma Area and Severity Index with melasma quality of life scale or dermatology life quality index scores. There is no difference in the melasma quality of life scale scores with different demographic variables including age, duration of disease, levels of education, and employment.
CONCLUSION: This study contributes to building evidence regarding the validity of melasma quality of life scale in accurately evaluating the effect of melasma on a patient's quality of life and the burden of disease in Singaporean women.

Entities:  

Year:  2016        PMID: 26962388      PMCID: PMC4756868     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  12 in total

1.  Melasma: measure of the impact on quality of life using the French version of MELASQOL after cross-cultural adaptation.

Authors:  Laurent Misery; Anne-Marie Schmitt; Sami Boussetta; Nora Rahhali; Charles Taieb
Journal:  Acta Derm Venereol       Date:  2010-05       Impact factor: 4.437

2.  Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.

Authors:  M M Chren; R J Lasek; A P Sahay; L P Sands
Journal:  J Cutan Med Surg       Date:  2001-03-21       Impact factor: 2.092

3.  Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.

Authors:  Asena Cigdem Dogramaci; Deniz Yurtman Havlucu; Tacettin Inandi; Rajesh Balkrishnan
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

4.  Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.

Authors:  T F Cestari; D Hexsel; M L Viegas; L Azulay; K Hassun; A R T Almeida; V R P A Rêgo; A M D Mendes; J W A Filho; H Junqueira
Journal:  Br J Dermatol       Date:  2006-12       Impact factor: 9.302

Review 5.  Melasma: a comprehensive update: part I.

Authors:  Vaneeta M Sheth; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2011-10       Impact factor: 11.527

Review 6.  Melasma. Etiologic and therapeutic considerations.

Authors:  P E Grimes
Journal:  Arch Dermatol       Date:  1995-12

7.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

8.  Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language.

Authors:  Arturo R Dominguez; Rajesh Balkrishnan; Allison R Ellzey; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2006-05-02       Impact factor: 11.527

9.  Development and validation of a health-related quality of life instrument for women with melasma.

Authors:  R Balkrishnan; A J McMichael; F T Camacho; F Saltzberg; T S Housman; S Grummer; S R Feldman; M-M Chren
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

10.  Effect of melasma on quality of life in a sample of women living in southern Brazil.

Authors:  F M Freitag; T F Cestari; L R Leopoldo; P Paludo; J C Boza
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-04-10       Impact factor: 6.166

View more
  9 in total

1.  Clinical efficacy of self-designed Xiaoban Huoxue Prescription on chloasma derived from liver stagnation and blood stasis.

Authors:  Ge Su; Xun Zhou
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of Polypodium Leucotomos Extract in the Treatment of Melasma in Asian Skin: A Pilot Study.

Authors:  Chee-Leok Goh; Sai Yee Chuah; Steven Tien; Guan Thng; María Alejandra Vitale; Arancha Delgado-Rubin
Journal:  J Clin Aesthet Dermatol       Date:  2018-03-01

3.  Quality of life in patients with melasma in Turkish women.

Authors:  Hacer Uyanikoglu; Mustafa Aksoy
Journal:  Dermatol Reports       Date:  2017-10-10

4.  Is There a Correlation between Severity of Melasma and Quality of Life?

Authors:  Nelva Karmila Jusuf; Imam Budi Putra; Mahdalena Mahdalena
Journal:  Open Access Maced J Med Sci       Date:  2019-08-25

5.  Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.

Authors:  Yuan Zhu; Xiaofang Zeng; Jieya Ying; Yujia Cai; Yu Qiu; Wenzhong Xiang
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

Review 6.  Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.

Authors:  Zuzanna Piętowska; Danuta Nowicka; Jacek C Szepietowski
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

7.  Trends in Use of Prescription Skin Lightening Creams.

Authors:  Dana S Saade; Mayra B C Maymone; Henriette De La Garza; Eric A Secemsky; Kevin F Kennedy; Neelam A Vashi
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

Review 8.  Photoprotection for Skin of Color.

Authors:  Jerry Tsai; Anna L Chien
Journal:  Am J Clin Dermatol       Date:  2022-01-19       Impact factor: 6.233

9.  Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.

Authors:  Maryam Karrabi; Mohammad Ali Mansournia; Ehsan Sharestanaki; Yeganeh Abdollahnejad; Mohammad Sahebkar
Journal:  Arch Dermatol Res       Date:  2020-09-02       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.